Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide

Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) with high-dose cyclophosphamide (PTCy) has resulted in a low incidence of graft-vs.-host disease (GVHD), graft failure, and non-relapse mortality. However, post-transplantation relapse remains a common cause of treatment failure in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Muñiz, Paula, Kwon, Mi, Carbonell, Diego, Chicano, María, Bailén, Rebeca, Oarbeascoa, Gillen, Suárez-González, Julia, Andrés-Zayas, Cristina, Menárguez, Javier, Dorado, Nieves, Gómez-Centurión, Ignacio, Anguita, Javier, Díez-Martín, José Luis, Martínez-Laperche, Carolina, Buño, Ismael
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027082/
https://ncbi.nlm.nih.gov/pubmed/33841425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.642087
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi